Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

Humanitas Clinical Institute of Rozzano, Milan, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:5City/State/Province:Milan
Treatments:ChemotherapyHospital:Humanitas Clinical Institute of Rozzano
Drugs:Journal:Link
Date:Apr 2008

Description:

Patients:
This study involved 30 malignant pleural mesothelioma patients, 73% of whom were male. The median patient age was 66 years.

Treatment:
Patients were treated with the chemotherapy agents gemcitabine and vinorelbine.

Toxicities:
There was one reported death due to pneumonitis (lung infection). Also reported were three cases of grade 3 neutropenia and one case each of grade 3 nausea/vomiting, fatigue, and constipation.

Results:
The reported median overall survival was 10.9 months.

Correspondence: Dr. Polo A. Zucali; email: [email protected]



Back